Lipid Droplets: Function, Structure, and Role in Disease

Lipid droplets are organelles found in nearly every cell type across nearly every branch of life, from yeast to humans, and their core job is storing fat in a form the cell can tap when it needs energy or building materials. For decades they were dismissed as inert globs of grease, but research over the past two decades has revealed them as dynamic, tightly regulated structures involved in everything from immune defense to the progression of liver disease, atherosclerosis, and neurodegeneration. Their architecture is unique among organelles, and understanding how they work opens a window into metabolic health and disease alike.

A Structure Unlike Any Other Organelle

Most organelles are enclosed by a two-layered lipid membrane. Lipid droplets break that rule. They have a hydrophobic core of neutral lipids, mainly triglycerides and cholesterol esters, wrapped in a single-layer phospholipid shell studded with a specific set of proteins.¹ That monolayer matters because it dictates which proteins can associate with the surface and how the droplet interacts with other organelles. Because the core is hydrophobic and the shell is only one lipid layer thick, proteins that anchor to lipid droplets use different strategies than those binding a standard bilayer membrane. The composition of the neutral lipid core also varies between cell types and metabolic states, making the lipidome of each droplet surprisingly context-dependent.²

This structure is ancient. The ability to store fat as cytoplasmic triglyceride droplets is conserved from baker’s yeast all the way to humans, and the gene families involved in that storage have been retained across evolutionary time.³ The conservation hints that lipid droplets confer a fundamental survival advantage, not just for energy storage, but for the many secondary roles researchers have been uncovering.

How Lipid Droplets Form and Grow

Lipid droplets are born in the endoplasmic reticulum. As neutral lipids accumulate between the two leaflets of the ER membrane, they eventually undergo phase separation, coalescing into a lens-shaped blob that buds outward into the cytoplasm. A protein called seipin plays a central role in this process. In yeast, seipin assembles into a ring of ten copies that forms a cage-like structure. The cage’s closed conformation enables triglycerides to concentrate and phase-separate, and it then switches to an open conformation to allow the growing droplet to bud off.⁴ Mutations in seipin cause severe lipodystrophy in humans, underscoring how important controlled droplet formation is for normal fat storage.

Once formed, lipid droplets can grow further by fusing with one another. A family of proteins called CIDE proteins drives this fusion through a multi-step process: they gather at the contact site between two droplets, form a concentrated plate, open lipid-permeable passageways through that plate, and then facilitate the transfer of neutral lipids from the smaller droplet into the larger one.⁵ This fusion mechanism explains why fat cells in white adipose tissue typically contain a single enormous lipid droplet rather than many small ones. One CIDE family member promotes lipid storage under normal feeding conditions, while others kick in during fasting or obesity to drive the formation of oversized droplets in the liver.⁶ A signaling lipid called PI(4)P marks certain droplets to recruit CIDE proteins and activate their fusion activity; removing PI(4)P from the droplet surface blocks the whole process.⁷

Protein Gatekeepers and Lipid Release

The surface of a lipid droplet is not bare. It is decorated with a family of proteins called perilipins that act as gatekeepers, controlling whether the fats inside stay locked away or get broken down. Most cells carry perilipins 2 and 3 on their small droplets, while specialized fat-storing cells also express perilipins 1, 4, and 5. Perilipins 1 and 5 are especially strict about restricting access: they physically block fat-digesting enzymes from reaching the neutral lipid core until a hormonal signal triggers their phosphorylation, which loosens their grip and allows lipolysis to proceed.⁸

The enzymes doing the actual fat breakdown work in a coordinated relay. Adipose triglyceride lipase performs the initial cut, splitting a triglyceride into a diglyceride and a free fatty acid. Hormone-sensitive lipase then takes over, efficiently breaking the diglyceride down further.⁹ This sequential action ensures that fat is released in an orderly, regulated way rather than in an uncontrolled flood.

Cells also have a second, entirely different route for emptying lipid droplets. Through a process called lipophagy, the cell’s recycling machinery wraps entire droplets in a membrane and delivers them to lysosomes, where lysosomal enzymes chew through the lipid contents.¹⁰ This pathway is especially active during prolonged starvation and in certain liver conditions.

Talking to Mitochondria and the ER

Lipid droplets do not float around in isolation. They form physical contact sites with other organelles, and the most important of these partnerships is with mitochondria. At these contact points, fatty acids move directly from the droplet surface into mitochondria for oxidation and energy production.¹¹ Perilipin 5 is the tether that holds the two organelles together. When cells are starved, PLIN5 gets phosphorylated, stimulating lipolysis on the droplet surface and channeling the freed fatty acids to a partner protein on the mitochondrial side called FATP4, which converts them into a form mitochondria can burn.¹²

Researchers have also identified a three-way junction where lipid droplets, the ER, and mitochondria all meet at once. These triple contact sites coordinate lipid transfer, storage decisions, and metabolic signaling across all three organelles simultaneously.¹³ The finding underscores that lipid droplets are integrated into a broader organelle network rather than being standalone storage tanks.

Buffering Against Toxic Lipids

Free fatty acids floating loose in the cytoplasm are dangerous. When they accumulate beyond what a cell can handle, they disrupt membranes, damage mitochondria, generate reactive oxygen species, and trigger a form of cell death called ferroptosis. Lipid droplets prevent this by acting as buffers, mopping up excess fatty acids, cholesterol, and ceramides and tucking them away as harmless neutral lipid species.¹⁴ In stressed cells, droplets also help maintain the cell’s energy balance and its ability to handle oxidative damage.¹⁵

This protective role extends beyond lipids. When severe stress overwhelms the cell’s protein-recycling system, lipid droplets can accept misfolded and harmful proteins, sequestering them away from the cytoplasm where they would otherwise form toxic aggregates.¹⁶ In cardiac endothelial cells, blocking lipid droplet formation worsened mitochondrial damage and lipid peroxide buildup when cells were challenged with excess fatty acids, confirming that droplet biogenesis is actively protective for the cell’s survival.¹⁷

An Unexpected Role in Immune Defense

One of the more surprising discoveries in recent years is that lipid droplets function as platforms for the innate immune system. When mammalian cells detect bacterial signals, a suite of host defense proteins assembles on the surfaces of lipid droplets, including antimicrobial peptides and enzymes that attack intracellular bacteria. At the same time, the droplets physically disengage from mitochondria, shifting the cell’s metabolism away from fat burning and toward an immune-ready state.¹⁸

Lipid droplets also play a role in antiviral defense. During viral infection, key antiviral sensing proteins and signaling molecules are recruited specifically to virus-induced lipid droplets, positioning them as early warning platforms that help the cell mount a rapid interferon response.¹⁹ The picture that emerges is of a dual-use organelle: it stores energy during good times and doubles as an immune command post during infection.

Liver Disease and Lipid Droplet Overload

When the liver accumulates too many lipid droplets, the result is steatosis, commonly known as fatty liver. When this occurs outside the context of alcohol or viral hepatitis, it falls under the umbrella of metabolic dysfunction-associated steatotic liver disease (MASLD). In its more severe form, called metabolic dysfunction-associated steatohepatitis (MASH), the excess droplets are accompanied by inflammation, hepatocyte injury, and fibrosis.²⁰ Far from being passive bystanders, lipid droplets actively contribute to disease progression by altering cell signaling, generating toxic lipid intermediates when their buffering capacity is overwhelmed, and disrupting normal liver cell function.²¹

The irony is that lipid droplets are simultaneously protective and harmful in the liver. Up to a point, packaging excess fat into droplets shields liver cells from the damage that free fatty acids would cause. But when lipid influx persistently exceeds what the cell can safely store or export, droplet composition and signaling change in ways that fuel the transition from simple steatosis to the inflammatory, fibrotic stage of the disease.

Foam Cells and Atherosclerosis

Lipid droplets also figure prominently in cardiovascular disease. Atherosclerosis begins when immune cells called macrophages take up excess cholesterol from the bloodstream and convert it into cholesterol esters stored in lipid droplets. When droplets accumulate to the point that the macrophage looks foamy under a microscope, the cell is called a foam cell, and foam cell formation is a hallmark of plaque development. Lipid droplet-associated proteins from both the perilipin and CIDE families regulate how these droplets form, grow, and stabilize inside macrophages, and manipulating those proteins has been shown to alter plaque progression.²² This makes lipid droplet biology relevant not just to metabolic specialists but to anyone thinking about cardiovascular risk.

Lipid Droplets in the Brain

Neurons and the glial cells that support them have their own lipid droplet dynamics, and disruptions in those dynamics are increasingly linked to neurodegeneration. When neuronal mitochondria malfunction and produce excessive reactive oxygen species, a key downstream consequence is the accumulation of lipid droplets in surrounding glial cells.²³ Changes in lipid metabolism and droplet formation within glia have been observed across models of multiple neurodegenerative diseases, though the exact role these droplets play, whether primarily protective or eventually harmful, remains under investigation.²⁴

In the context of Parkinson’s disease, dopaminergic neurons that accumulate lipids show signs of cellular senescence, a state of irreversible growth arrest accompanied by inflammatory signaling. Perilipin 2, one of the droplet surface proteins discussed earlier, is significantly upregulated in these senescent neurons, pointing to an enrichment of lipid droplets as part of the aging and degenerative process.²⁵ Whether targeting lipid droplet accumulation could slow neuronal aging is an open and actively studied question.

Droplet Size Shapes Tissue Function

The physical size and number of lipid droplets in a cell are not random; they carry functional meaning. White adipose tissue stores energy for the long term, so its cells contain a single giant droplet that minimizes surface area relative to volume. That geometry limits the rate of lipolysis from the surface, making the fat harder to access but efficient to store and export. Brown adipose tissue, which burns fat to generate heat, takes the opposite approach: it packs many small droplets with a large combined surface area, giving lipases more room to work and positioning the freed fatty acids close to the numerous mitochondria that need them.²⁶ The CIDE family of fusion proteins discussed earlier is central to establishing these contrasting architectures, with different isoforms promoting or inhibiting droplet fusion in each tissue type.

How Viruses and Tumors Exploit Lipid Droplets

Because lipid droplets are such rich sources of both energy and membrane-building lipids, pathogens have evolved ways to hijack them. Hepatitis C virus, for instance, co-opts lipid droplets as assembly platforms for producing infectious viral particles.²⁷ More broadly, enveloped viruses need lipids for their outer coats, and positive-sense RNA viruses need them for the membranous compartments where they replicate, so many viruses have strategies to boost droplet formation or raid droplet contents.²⁸

Cancer cells pull a similar trick for different reasons. In prostate cancer, low-oxygen conditions trigger lipid droplet accumulation that rewires the cell’s lipid profile, shifting fats away from species vulnerable to oxidative damage and into more stable neutral lipid forms stored in droplets. The result is increased resistance to ferroptosis, a form of cell death that depends on lipid peroxidation.²⁹ In other words, the same buffering function that protects normal cells from lipid damage can be co-opted by tumor cells to resist being killed.

Watching Droplets in Living Cells

Much of what we now know about lipid droplet behavior comes from advances in imaging. Fluorescent probes that light up only when they embed in a lipid droplet allow researchers to track droplet birth, growth, movement, and interaction with other organelles in real time. Some of these probes are stable enough to monitor cells for two days straight, and by using probes of different colors, scientists can distinguish newly formed droplets from older ones and even catch whole droplets being transferred between neighboring cells.³⁰ Label-free approaches using stimulated Raman scattering microscopy can quantify lipid content and metabolism in individual droplets without adding any dye at all, providing a chemical portrait of each droplet that links directly to the cell’s metabolic state.³¹ These tools have been essential for moving the field from static snapshots to the dynamic, real-time understanding that underpins many of the disease connections described above.

Therapeutic Interest

Given how many diseases involve lipid droplet dysfunction, researchers are actively exploring whether targeting droplets or their associated proteins could offer new treatments. Natural compounds that regulate lipid droplet formation, growth, and protein interactions have shown promise in preclinical models of metabolic diseases.³² The challenge is precision. Because lipid droplets serve protective functions in healthy cells, any intervention needs to selectively correct the dysregulated aspects of droplet biology in disease without undermining the organelle’s housekeeping roles. Blocking CIDE-mediated fusion might limit pathological droplet expansion in the liver, for example, but the same fusion machinery is essential for normal fat storage in adipose tissue. Similarly, promoting lipolysis might help clear hepatic steatosis but could worsen lipotoxicity if the freed fatty acids overwhelm mitochondrial capacity. These trade-offs are why lipid droplet-targeted therapies remain in the early stages, but the sheer number of disease connections keeps the field moving quickly.